To Get more Insights,  Request A Free Sample 

Opportunity Analysis

• Constant Surveillance through Wearable Patches.

The diagnostic ultrasound market is pivoting toward autonomous, wearable form factors. Innovations of 2024 showed adhesive ultrasound patches that are in a position to track blood flow and organ function on 24 continuous hour basis. Such hands-free devices are wireless in nature, which means that a sonographer does not have to be present. This type of technology provides an enormous opportunity in non-hospital care and post-operative care. The developers are shifting to dynamic and longitudinal data collection as opposed to static imaging. The capability to record physiological changes not on a minute but on a daily basis is an additional revenue source focused on data subscription services and no more as hardware sales.

• Synchronous Remote Teleguidance Models.

The rural unexploited diagnostic ultrasound markets are being opened through real-time remote collaboration. It is now possible to have trained a beginner user to follow the direction of a centralised expert on the hand movements with sub-second latency using new software platforms. An expert in a big city will be able to regulate the environment of a device in a thousand-mile distance. In 2025, the US added reimbursement codes to address these synchronous tele-ultrasound consults. These changes in policies encourage health system to install ultrasound in ambulances and remote clinics. The market opportunity is in the sale of integrated software-hardware environment which ensures expert level diagnostics irrespective of the physical location of the operator.

Demand Analysis 

HFR 4D Echocardiography is the Future of Structural Heart Interventions and Care.

Cardiology departments drive immense demand within the Diagnostic ultrasound market due to the rising complexity of structural heart procedures. New procedures, such as TAVR and MitralClip demand higher imaging rates than previous processes can achieve. The new 2024 premium echocardiography systems have volume rates of over 240 Hz in 4D mode. These systems rely on matrix probe with more than 9,000 active elements to bring out anatomy in real time. It enables simultaneous visualization of 12 slice planes due to hardware improvement. This processing capability brings down the time needed to measure the volumes of the chamber of the heart to less than 15 seconds.

These specifications are a priority of clinicians because they guarantee safety when making delicate repairs on valves in the diagnostic ultrasound market. Advanced cardiovascular ultrasound consoles are also available with storage capability of up to 4 Terabytes to store large volumes of data. The most recent transesophageal probes are less than 180 grams, which necessitates less stress on the operator during lengthy procedures. To obtain these capabilities, facilities are spending US 200, 000 or more per unit. The new CPT codes that came in place in 2025 offer reimbursement of US 150 per specialized 3D echo study. The use of 2D assessment in all valve interventions is another factor that accelerates adoption due to clinical guidelines that require 3D assessment. Therefore, hospitals are quick to eliminate old units to abide by such absolute technical standards.

High Frequency Transducers Amplify Accuracy In Musculoskeletal And Sports Medicine Diagnostic.

Musculoskeletal (MSK) applications are a rapidly expanding sector defining Diagnostic ultrasound market procurement. Extreme resolution is required in sports medicine clinics and rheumatology centers to visualize of superficial nerves and ligaments. In 2025, manufacturers reacted and published transducers that can operate at frequencies up to 24 MHz. Such ultra-high-frequency probes have an axial resolution as fine as 0.05 millimeters. This accuracy makes it possible to visualize nerve fascicles that were otherwise not seen before due to older 12 MHz scanners. The tools are used by clinicians to direct needle injections with less than millimeter precision.

The demand is also triggered by operational efficiency metrics in this segment. MSK portable units have now been reduced to less than 15 seconds to boot. These systems have batteries that have a continuous scanning life of 4 hours per charge. The devices have hard casings which have been tested to handle 1.2 meter drops. The 20 to 30 scans per day done by these ruggedized tools are normally done in clinics. In the hospital outpatient, the average reimbursement of soft tissue ultrasound guidance through Medicare amounts to US$ 120. They are available in more than 15 different anatomical presets which are joint specific. These particular, measured performance benefits are the key to the change towards office-based orthopedics.

Segmental Analysis 

Improving 2D Imaging Precision to Increase Workflow and Clinical Efficiency.

Cost-effectiveness and fundamental utility continue to drive diagnostic ultrasound market expansion. As a result, it has been observed that the 2D segment has dominated the highest market share of 36.55% in 2024. These systems are important in primary care facilities because they are vital in making quick initial assessments. In line with this need, GE HealthCare reinforced the sector by introducing the Venue Sprint in September 2024 to streamline the critical care processes. Moreover, Philips has launched its Elevate software at the beginning of 2025 and it is specifically created to automate basic 2D imaging. The 2D Point-of-Care Ultrasound (POCUS) was also included in the priorities of emergency departments during 2024 to conduct immediate trauma assessment. In the meantime, developing countries preferred such systems to brain tumor screenings because it was less expensive to acquire. Also the innovation of high-frequency transducer came later in 2024 which enhanced superficial resolution to a large extent. Conclusively, 2D Diagnostic ultrasound will not go away anytime soon in the day-to-day medical practice.

• On November 26, 2024, Acetara Labs explained tissue differentiation through harmonic imaging discoveries.
• 2025 Aplio Beyond by Canon Medical employs Superb Microvascular Imaging to find out blood flow.
• Quantification in cardiac measurements is now automated by use of AI to minimize human error.

Regulatory bodies continue to back this foundational technology in the global diagnostic ultrasound market. As an example, the FDA approved MyLab A50 by Esaote in August 2025 in a variety of clinical environments. In 2024, hospitals increased their purchase of basic units to address an increase in the number of patients. Furthermore, with the current incorporation of AI, it is possible to measure these platforms automatically. Exams are quicker and regular as such updates. Consequently, Diagnostic ultrasound has retained its position as the standard of vascular access guidance.

Making Maternal Care Revolutionary with High-tech Automated Imaging and Diagnostics.

Rising global birth rates and a focus on fetal health fuel growth across the diagnostic ultrasound market. Consequently, the obstetrics/gynecology segment had a large proportion in 2024. Specialist systems were adopted by clinicians to provide high-risk pregnancies throughout the year. To fulfill this requirement, Sonio was approved by FDA in early 2025 to use its AI-driven Suspect solution called Sonio Suspect. Moreover, Samsung launched Live ViewAssist at the end of 2024 that shortens the number of keystrokes in exams. Increased volumes of scans in the US were also driven by expanded Medicaid cover. Moreover, the models of GE HealthCare 2025 include SonoLystLive to automatize gestational measurements. The frequency of uterine fibroids necessitated high-level gynecological scanning in 2024. Diagnostic ultrasound is very crucial in the health of the fetus.

• In 2025, the assessment of the pelvic dysfunction was enhanced by the software update called SonoPelvicFloor.
• In 2024, public funding was greatly increased in regard to maternal health equipment upgrades.
• Quick acquiring 3D/4D became the norm as far as the milestones of fetal development were concerned.

In November 2025, Philips released a new EPIQ Elite system that uses AI segmentation. The tool automatically outlines fetal anatomy for better accuracy, adding fuel to the diagnostic ultrasound market growth. In the meantime, the systems with the ability to detect PCOS early became in demand. Manufacturers reacted by placing certain health measures of women into devices. These innovations have direct influence on the outcomes of neonatology. Therefore, Diagnostic ultrasound still remains the most significant mode of protecting reproductive health.

High Performance Trolley Systems High Performance Trolley Systems of Critical Hospital Workflows and Stability.

Stability and high-quality image is required in hospitals. Therefore, the trolley segment has captured the biggest market share of 67.86% in diagnostic ultrasound market based on portability. Cart based units can accommodate various types of probes and thus enable clinicians to alternate quickly between examinations. Samsung presented its Hera Z20 trolley at the Society of maternal-fetal Medicine 2025 conference to demonstrate ergonomic additions. Likewise, GE HealthCare obtained the FDA clearance of the Voluson Expert trolley series in early 2025. These large units have the processing power that is needed to handle complex cardiac scans. Moreover, Esaote has also introduced the MyLab C30 in 2025 which is aimed at interventional radiology. In 2025, Aplio Beyond trolley is also granted its CE Mark by Canon Medical. Diagnostic ultrasound uses these strong platforms in deep penetration.

• Multi-probe ports provide an opportunity to switch the transducer in real-time to perform a thorough examination of the patient.
• New high capacity 2025 batteries allow rounding the wards at long periods with little or no recharging.
• The fusion imaging is now being able to incorporate CT information on the trolley screen.

Clinicians in the diagnostic ultrasound market favor these systems because they prevent risky patient transfers. High-end carts are used to bring high-tech imaging to the ICU bedside. Also, Siemens Healthineers presented the Sequoia 3.5 trolley with Abdomen AI in early 2025. The size is synonymous with computing power in this industry. As a result, the dominance of the hospital revenue in 2024 is associated with the installation of such versatile machines. Finally, the Diagnostic ultrasound on trolley architecture is still the standard of the stationary clinical environment.

 To Understand More About this Research:  Request A Free Sample 

Regional Analysis 

Domination of the North American Market is Ensured by High Rates of Reimbursement and Government Contracts

North America currently commands the diagnostic ultrasound market with over 31.95% market share. This is a leading position that is reinforced by high procedural reimbursement rates. CPT code 76705 (abdominal aorta screening) was listed in the 2025 CMS fee schedule at a specific price of US 118.46. The average of abdominal scans being done each per machine is reported to be 32 in US outpatient imaging centers. The volumes of procurement are huge in the continent as the result of federal efforts. In January 2025, the US Department of Defense granted US $ 45 million in the form of a contract to deployable ultrasound units. Hospitals in New York alone procured 450 new cart-based systems in the Q1 2025 procurement cycle. The financial dominance of the region and the density of infrastructure is cemented in such buying power.

Educational and clinical frameworks further support this expansion in the diagnostic ultrasound market. The number of US medical students who actively used portable ultrasound devices in 2024-2025 academic year is more than 12,500. The aggregate number of echocardiograms undertaken across the Mayo campuses was 85,000 in 2024. The HCA Healthcare invested US$ 300 million in upgrades of emergency rooms that also involved sophisticated imaging equipment. In 2024, the coverage of Medicare was expanded to cover up to 8 fetal ultrasounds per year in the case of high-risk pregnancy. In 2025, Canada Health Infoway has particularly set aside US$ 40 million to fund interoperable diagnostic imaging projects. In 2024, the California state grants will give US 12 million towards the rural POCUS training programs. These numbers are evidence of the fact that the market is establishing clinical roots.

Asian market is Growing As Mass Production and Country Modernization Efforts Adds Fuel

Manufacturers in Asia diagnostic ultrasound market  are aggressively scaling output to meet both local and global needs. The Shenzhen plant of Mindray has been working on 12,000 probes per month in 2024. Within the same year (Q3 2024), Samsung Medison sold 4,500 units exported out of its Korean plant. The high amount of government modernization projects is driving demand. In late 2024, the Chinese project of 3,000 separate ultrasound units was ordered to set up rural centers by the project entitled Thousand County. In February 2025, India AIIMS network bidders were tendering 150 premium cardiac ultrasound machines. In 2025, Indonesia has specifically spent US 25 million on primary care equipment renovations.

Reimbursement structures and budget allocations ensure sustained device usage in the regional diagnostic ultrasound market. An example is that in Japan, MHLW fixed the cost of contrast-enhanced ultrasound to reimbursement at JPY 12,000 in 2024. In 2024, the Medicare Benefits Schedule of Australia included the price of the abdominal scans as AUD 110.50. As part of its budget 2025, South Korea has allocated KRW 50 billion towards modernization of medical imaging.

More European demand is anchored by Public Health Fleet Renewals and Robust Procedural Volumes

Public health systems across Europe diagnostic ultrasound market are heavily investing in fleet renewal programs. In 2024 NHS England acquired 500 diagnostic ultrasound units to be used by Community Diagnostic Centres. The AP-HP hospital network in France established a EUR 25 million imaging equipment maintenance budget by 2025. In 2024, the hospital industry of Germany documented 14 million ultrasound tests, which creates an unremitting demand in consumable items and services. These throughputs are hastening equipment turnover to satisfy them. By 2025 statistics, Swiss hospitals have an average cart-based system replacement cycle of 6 years.

Private sector and regional investments complement these national strategies in the diagnostic ultrasound market. In 2024, Spanish health authorities put a tender on the renewal of an ultrasound fleet worth a US$ 15 million. In March 2025, the Lombardy region of Italy financed the acquisition of 120 portable scanners. In 2025, the average UK prices of a standard scan in the UK private sector were GBP 150. In 2024, Philips transported 2,000 EPIQ systems manufactured in its plant in Hamburg to the European customers. The study of 60 daily liver elastography was done in Charite - Universitatsmedizin Berlin. ECR 2024 had an attendance of 30,000, according to the European Society of Radiology. The Diagnostic ultrasound market here is defined by modernization and high-throughput requirements.

Market Tyrants: The Big Four Reshaping Diagnostics Landscape Globally.

GE HealthCare, Philips, Siemens Healthineers, and Mindray dominate the landscape of the global diagnostic ultrasound market by aggressively pivoting toward AI-enhanced and portable solutions to meet surging patient volumes. GE HealthCare has taken the handheld revolution with its Vscan Air SL, which directly responds to the need of decentralized, bedside imaging. Siemens Healthineers is also transforming the clinical processes with its Acuson Sequoia 3.5; the system employs the use of the AI Abdomen to minimize the hand movement of the sonographer by 89 percent; this is a vital innovation to address the workforce shortages in the world. Philips persists in shaking the market with its adaptable Lumify subscription plan, which reduces entry obstacles to providers, whereas Mindray has managed to gain a top 3 world ranking, by broadening its premium ultrasound offering by more than 25 percent to fulfill complex diagnostic requirements.

Financial fortitude and relentless R&D investment underpin their unshakeable leadership in the diagnostic ultrasound market. Investment in research and development, such as allocating US$ 324 million to R&D in Q1 2024 alone, to drive the next generation of chip-on-probe technologies was a demonstration of this commitment by GE HealthCare. This is due to the fact that Philips is capitalizing on the power of its Diagnosis and Treatment segment that has generated EUR 8.8 billion to drive sustainability, with a 24% of sales of circular revenue streams. In the meantime, strong 30% international growth rate by Mindray indicates its supremacy in new markets. The four giants successfully determine the direction that the sector will take in the next 3 years, towards a future of US$ 16 billion of capital needs because of their alignment between massive capital allocation and clinical needs of speed, automation and affordability.

Top 6 Recent Developments Shaping Diagnostic Ultrasound Market

1. In July 2024, GE HealthCare acquired the Clinical AI business of Intelligent Ultrasound to develop automated image analysis at the cost of US$ 51 million.
2. In May 2024, Samsung Medison acquired French AI company Sonio in the amount of about US$ 92.7 million to enhance the prenatal diagnostics.
3. In March 2024, Butterfly Network issued US$ 50 million through a registered direct offering to fund the commercial launch of the iQ3 system.
4. In April 2024, GE HealthCare purchased MIM Software so they can combine digital workflow solutions and advanced imaging analytics with their ultrasound portfolio.
5. In May 2024, SpectraWAVE raised US $50 million in a Series B round to develop intravascular imaging technology using a combination of ultra-sound imaging and optical technology.
6. In April 2024, Think Sono announced a FDA clearance of their deep vein thrombosis AI guidance by raising US$ 2.7 million in an extension round of seed funding.

Top Companies in the Diagnostic Ultrasound Market

• Canon Medical Systems Corporation
• Esaote S.P
• GE GealthCare Technologies Inc.
• Hologi Inc.
• Konica Minolta Inc.
• Koninklijke Philips N.V.
• Samsung Electronics Co. Ltd.
• Siemens Healthineers AG
• Fujifilm Holdings Corporation
• Mindray Medical International Limited
• KronosMD Inc.
• Other Prominent Players

Market Segmentation Overview

By Technology

• 2D
• 3D and 4D
• Doppler

By Portability

• Trolley
• Compact/Handheld

By Application

• General Imaging
• Cardiology
• Obstetrics/Gynecology
• Others

By End-use

• Hospitals
• Maternity Centers
• Others

By Region

• North America
  • The US
  • Canada
  • Mexico
• Europe
  • Western Europe
    • The UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia and New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
• South America
  • Argentina
  • Brazil
  • Rest of South America